In fact, with 3 billion spent annually on combating malaria, it is very important to develop vaccines and diversified treatments, given the disease's resistance to current antimalarial treatments.

The European Union is a major contributor to the development and effective implementation of evidence based malaria control programmes and to work on increasing the affordability of antimalarial medicines.